Assessment of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences

被引:24
作者
Njouom, R [1 ]
Pasquier, C [1 ]
Sandres-Sauné, K [1 ]
Harter, A [1 ]
Souyris, C [1 ]
Izopet, J [1 ]
机构
[1] CHU Toulouse Purpan, Virol Lab, F-31059 Toulouse, France
关键词
HIV-1; env; pol; subtypes; plasma; Cameroon;
D O I
10.1016/S0166-0934(03)00080-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Phylogenetic analysis of human immunodeficiency virus type 1 (HIV-1) pol gene is a useful method for subtyping European strains of HIV-1. The suitability of this method for genetically diverse African strains was evaluated by comparing HIV-1 subtyping of Cameroon strains using a long fragment of the pol gene sequence to the findings obtained using env gene sequences. When the pol gene could not be amplified, the reverse transcriptase (RT) or the protease (PR) genes were used. Phylogenetic analysis of the env C2/V3 gene sequences of 60 HIV-1 isolates showed 52 to be subtype A, 2 subtype G, plus one each of subtypes C, F2 and H, with 3 subtypes not determined. A long fragment of the pol gene was amplified successfully and sequenced in 23% of cases. The RT region was amplified for 42% of the samples that could not be typed by analysing the long fragment, and the PR gene was amplified for 40% of them. Thus, 63% of samples were typable. Env and pol gene subtypings were in agreement in 86% of cases. It is concluded that the phylogenetic analysis of pol gene sequences is not a practical method for HIV-1 subtyping in areas of high subtype diversity, despite the good agreement between the env and pol gene subtypings. However, it can be a useful method for HIV-1 subtyping, provided that the gene is amplifiable. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 33 条
[1]   The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon [J].
Carr, JK ;
Torimiro, JN ;
Wolfe, ND ;
Eitel, MN ;
Kim, B ;
Sanders-Buell, E ;
Jagodzinski, LL ;
Gotte, D ;
Burke, DS ;
Birx, DL ;
McCutchan, FE .
VIROLOGY, 2001, 286 (01) :168-181
[2]   Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998:: a French nationwide study [J].
Descamps, D ;
Calvez, V ;
Izopet, J ;
Bluffet-Janvresse, C ;
Schmuck, A ;
Colson, P ;
Ruffault, A ;
Maillard, A ;
Masquelier, B ;
Cottalorda, J ;
Harzic, M ;
Brun-Vézinet, F ;
Costagliola, D .
AIDS, 2001, 15 (14) :1777-1782
[3]   Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon [J].
Fonjungo, PN ;
Mpoudi, EN ;
Torimiro, JN ;
Alemnji, GA ;
Eno, LT ;
Nkengasong, JN ;
Gao, F ;
Rayfield, M ;
Folks, TM ;
Pieniazek, D ;
Lal, RB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) :1319-1324
[4]   Human immunodeficiency virus type 1 group M protease in Cameroon: Genetic diversity and protease inhibitor mutational features [J].
Fonjungo, PN ;
Mpoudi, EN ;
Torimiro, JN ;
Alemnji, GA ;
Eno, LT ;
Lyonga, EJ ;
Nkengasong, JN ;
Lal, RB ;
Rayfield, M ;
Kalish, ML ;
Folks, TM ;
Pieniazek, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :837-845
[5]   A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 [J].
Gao, F ;
Robertson, DL ;
Carruthers, CD ;
Morrison, SG ;
Jian, BX ;
Chen, YL ;
Barré-Sinoussi, F ;
Girard, M ;
Srinivasan, A ;
Abimiku, AG ;
Shaw, GM ;
Sharp, PM ;
Hahn, BH .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5680-5698
[6]  
GURTLER LG, 1994, J VIROL, V68, P1581
[7]   HIV-1 genetic variability in Cameroon [J].
Heyndrickx, L ;
Janssens, W ;
Ndumbe, PM ;
Vereecken, K ;
Coppens, S ;
De Houwer, K ;
Fransen, K ;
Van der Auwera, G ;
van der Groen, G .
AIDS, 2000, 14 (12) :1862-1864
[8]   Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel [J].
Hirsch, MS ;
Brun-Vézinet, F ;
D'Aquila, RT ;
Hammer, SM ;
Johnson, VA ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Clotet, B ;
Conway, B ;
Demeter, LM ;
Vella, S ;
Jacobsen, DM ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2417-2426
[9]   Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen [J].
Izopet, J ;
Massip, P ;
Souyris, C ;
Sandres, K ;
Puissant, B ;
Obadia, M ;
Pasquier, C ;
Bonnet, E ;
Marchou, B ;
Puel, J .
AIDS, 2000, 14 (15) :2247-2255